Literature DB >> 31468350

SMARCB1 (INI-1)-Deficient Adenocarcinoma of the Sinonasal Tract: A Potentially Under-Recognized form of Sinonasal Adenocarcinoma with Occasional Yolk Sac Tumor-Like Features.

Akeesha A Shah1, Deepali Jain2, Emad Ababneh1, Abbas Agaimy3, Aaron P Hoschar1, Christopher C Griffith1,4, Kelly R Magliocca4, Bruce M Wenig5, Lisa M Rooper6, Justin A Bishop7.   

Abstract

The classification of sinonasal adenocarcinoma (SNAC) is complex. The high-grade, non-intestinal SNAC group is particularly heterogeneous, with tumors showing widely variable morphology. SMARCB1 (INI-1)-deficient sinonasal carcinoma is a newly described, aggressive tumor that usually resembles sinonasal undifferentiated carcinoma (SNUC) or non-keratinizing squamous cell carcinoma; however, glandular differentiation has been rarely reported and this feature may be under-recognized. We present a dedicated series of 12 SMARCB1-deficient SNACs. All tumors had an oncocytoid/plasmacytoid cytomorphology with variable degrees of glandular differentiation consisting of tubules and cribriform structures with foci of intracellular or intraluminal mucin. Three of 12 tumors exhibited foci of yolk sac tumor-like histologic features. The tumors were uniformly high-grade, with nuclear pleomorphism, elevated mitotic rates and frequent necrosis. By immunohistochemistry, all tumors were entirely SMARCB1-deficient, and 10 of 12 were CK7-positive. Occasional expression of CDX2 (4 of 12), CK20 (3 of 12), and p40 (3 of 10) was seen. Expression of yolk sac markers was variably present in tumors that harbored yolk sac-like areas but also tumors that did not: glypican-3 (10 of 11), SALL4 (6 of 11), HepPar-1 (4 of 11), PLAP (1 of 10), and AFP (1 of 11). SMARCB1-deficient sinonasal carcinoma, particularly the oncocytoid/plasmacytoid form, can demonstrate variable degrees of glandular differentiation. This unexpected morphology combined with variable immunohistochemical results may lead to misdiagnoses of high-grade intestinal or non-intestinal SNAC, myoepithelial carcinoma, or even yolk sac tumor or metastatic hepatocellular carcinoma.

Entities:  

Keywords:  Adenocarcinoma; INI-1; SMARCB1; SMARCB1-deficient sinonasal carcinoma; Sinonasal; Yolk sac tumor

Mesh:

Substances:

Year:  2019        PMID: 31468350      PMCID: PMC7235142          DOI: 10.1007/s12105-019-01065-7

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  1 in total

Review 1.  High-Grade Sinonasal Carcinoma: Classification Through Molecular Profiling.

Authors:  Julie Guilmette; Peter M Sadow
Journal:  Arch Pathol Lab Med       Date:  2019-02-19       Impact factor: 5.534

  1 in total
  9 in total

Review 1.  Sinonasal SMARCB1 (INI1) Deficient Carcinoma with Yolk Sac Tumor Differentiation: A Case Report and Treatment Options.

Authors:  Burak Hazir; Berkay Şímșek; Arzu Erdemír; Fatih Gürler; Ozan Yazici; Yusuf Kizil; Utku Aydíl
Journal:  Head Neck Pathol       Date:  2021-08-21

Review 2.  SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma: A Systematic Review and Pooled Analysis of Treatment Outcomes.

Authors:  Victor Ho-Fun Lee; Raymond King-Yin Tsang; Anthony Wing Ip Lo; Sum-Yin Chan; Joseph Chun-Kit Chung; Chi-Chung Tong; To-Wai Leung; Dora Lai-Wan Kwong
Journal:  Cancers (Basel)       Date:  2022-07-05       Impact factor: 6.575

Review 3.  Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Nasal Cavity, Paranasal Sinuses and Skull Base.

Authors:  Lester D R Thompson; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2022-03-21

4.  Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: SWI/SNF-deficient Sinonasal Neoplasms: An Overview.

Authors:  Abbas Agaimy
Journal:  Head Neck Pathol       Date:  2022-03-21

5.  Genetic basis of SMARCB1 protein loss in 22 sinonasal carcinomas.

Authors:  Snjezana Dogan; Paolo Cotzia; Ryan N Ptashkin; Gouri J Nanjangud; Bin Xu; Amir Momeni Boroujeni; Marc A Cohen; David G Pfister; Manju L Prasad; Cristina R Antonescu; Yingbei Chen; Mrinal M Gounder
Journal:  Hum Pathol       Date:  2020-08-18       Impact factor: 3.466

6.  INI-1-Deficient Sinonasal Carcinoma: Case Report with Emphasis on Differential Diagnosis.

Authors:  Anwaar M Alsayed; Eman A Aljufairi; Amjad O Alshammari; Khalid A Alsindi; Omar A Sabra
Journal:  Case Rep Pathol       Date:  2022-03-30

Review 7.  Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment.

Authors:  Mario Turri-Zanoni; Giacomo Gravante; Paolo Castelnuovo
Journal:  Curr Oncol Rep       Date:  2022-01-20       Impact factor: 5.075

8.  Primary and Secondary/ Metastatic Salivary Duct Carcinoma Presenting within the Sinonasal Tract.

Authors:  Abbas Agaimy; Sarina K Mueller; Justin A Bishop; Simion I Chiosea
Journal:  Head Neck Pathol       Date:  2021-01-11

Review 9.  Towards a Molecular Classification of Sinonasal Carcinomas: Clinical Implications and Opportunities.

Authors:  Cecilia Taverna; Abbas Agaimy; Alessandro Franchi
Journal:  Cancers (Basel)       Date:  2022-03-12       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.